Health Care & Life Sciences » Pharmaceuticals | Sun Pharma Advanced Research Co.

Sun Pharma Advanced Research Co. | Cash Flow

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
343,242.00
395,200.00
699,920.00
1,190,384.00
2,459,737.00
Depreciation, Depletion & Amortization
38,509.00
75,182.00
78,572.00
82,397.00
81,846.00
Other Funds
178,050.00
29,714.00
132,722.00
216,773.00
133,620.00
Funds from Operations
203,701.00
349,732.00
754,070.00
1,324,760.00
2,511,511.00
Changes in Working Capital
97,993.00
21,500.00
304,058.00
128,648.00
204,765.00
Net Operating Cash Flow
301,694.00
371,232.00
450,012.00
1,196,112.00
1,816,988.00
Capital Expenditures
36,740.00
80,949.00
123,283.00
85,796.00
326,302.00
Sale of Fixed Assets & Businesses
747.00
1,847.00
5,209.00
1,644.00
149,470.00
Purchase/Sale of Investments
948,862.00
65,576.00
867.00
92,731.00
881,468.00
Net Investing Cash Flow
412,869.00
486,474.00
137,938.00
176,883.00
1,058,300.00
Issuance/Reduction of Debt, Net
723,460.00
9,733.00
515,355.00
526,104.00
8,522.00
Net Financing Cash Flow
718,021.00
9,530.00
520,513.00
1,968,997.00
2,241,479.00
Net Change in Cash
3,168.00
106,247.00
66,341.00
595,838.00
633,809.00
Free Cash Flow
264,954.00
452,181.00
573,295.00
1,281,908.00
2,143,290.00
Other Sources
500,000.00
500,000.00
-
-
-
Change in Capital Stock
5,439.00
203.00
5,158.00
2,495,101.00
2,250,001.00
Exchange Rate Effect
290.00
535.00
1,096.00
164.00
-
Other Uses
1,000,000.00
-
18,997.00
-
-
Extraordinaries
-
-
-
-
489,758.00

About Sun Pharma Advanced Research

View Profile
Address
17 B Mahal Industrial Estate
Mumbai Maharashtra 400093
India
Employees -
Website http://www.sunpharma.in
Updated 09/14/2018
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. Its projects include new chemical entity research and novel drug delivery systems. The company was founded on March 1, 2006 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.